Close Menu

NEW YORK – OraSure Technologies reported after the close of the market on Tuesday that its second quarter revenues fell 11 percent year over year, driven by a 4 percent dip in net product revenues during that period.

For the three months ended June 30, the point-of-care diagnostic testing and specimen collection device manufacturer reported revenues of $38.8 million, down from $43.6 million a year earlier and missing the average Wall Street estimate of $41.5 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.